1st Circuit Affirms Dismissal Of All But 1 Fabrazyme Shortage Claim

Mealey's (June 1, 2016, 7:00 AM EDT) -- BOSTON — The First Circuit U.S. Court of Appeals on May 23 said only one plaintiff in two class actions pleaded an injury claim from a shortage of the drug Fabrazyme while the others failed to do so (Anita Hochendoner, et al. v. Genzyme Corporation, No. 15-1446, Philip Adamo, et al. v. Genzyme Corporation, No. 15-1447, 1st Cir.; 2016 U.S. App. LEXIS 9438)....

Attached Documents

Related Sections